1Cheng EH,Kirach DG,Clem RJ,et al.Coaversion of Bcl-2 to Bax like death effector by caspases.Sclence 1997;278:1966-1968.
2Victor L.Multidrug realstance:molecular mechanisms and clinical relevance.Cancer Chemoth Pharmacol 1997;40:S3-S8.
3Cordon-Cardo C,O'Brien J,Bocoim J,et al .Expression if multidrug resistance gene product in hummun normal and tumor tissue J Histochem 1990;38:1277-1287.
4Anil K,Sood MD,Richard E,et al .Drug resistance in dvarian cancer:form the laboratory to clinic Obstet Gynecol 1998;92:312-319.
5Nooter K,Multidrug resistance(mdr)genes in human cancer.Br J Cancer 1991;63:663-669.
6Loe D,Deeley R,Cole S.Biology of the multidrug-resistance-associated protein ,MRP,Eur J Cancer 1996;32A:945-957.
7Kool M de Hass M,Scheffer GL,et al.Analysis of exprssion of cMOAT (MRP2),MRP3,MRP4,and MRP5,homologues of the multidrug resistance associsted protein gene (MRP)in human oancer cell line .Cancer Res 1997;57:3537-3547.
8Abbaszadegan MR,Futrcher BW,Klimecki WT,et al ,Analysis of multidrug resistance-associated protein (MRP) measenger RNA in mormal and malignsnt hemstopoietic cell Cancer Res 1994;54:4676-4679.
9Schneider E,Cowan KH,Bader H,et al ,Increased expression of the multidrug resistance-associated protein gene in relspsed acute leukmis .Blood 1995:85:186-193.
10Dingemans AM,Van der Valk P,Expression of human vanlt protein LRP in human lung cancer samples and normal lung tissue.Ann Oncol 1996;7:625-630.
